LongeVC

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage...

Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases...

LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis...

LongeVC's comparative indices for 2023 show slight improvements in net turnover, equity capital, fixed assets, balance, tangible assets, and liquidity...

LongeVC's portfolio company Longenesis has partnered with Novartis Baltics on a pilot project to transform cardiovascular disease treatment and prevention in Latvia...

Hyeyoung Eléonore S. has joined LongeVC as a Venture Scout in Norway...

LongeVC has invested in Glyphic Biotechnologies, which is developing single-molecule protein sequencing technology...